Literature DB >> 2528297

Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations.

F B Hollinger1.   

Abstract

The clinical course and immunodiagnosis of hepatitis B infection is discussed. Immunization is necessary to prevent the clinical disease, the development of carriers, and the transmission of the hepatitis B virus to susceptible persons. Host factors that can curtail the immune response include increasing age, obesity, smoking cigarettes, and having a medical condition that compromises the immune system. Increasing the dose of vaccine, administering the inoculations intramuscularly, and giving the vaccine more frequently can enhance the immune response. The duration of immunity following vaccination has not yet been defined, but booster dose guidelines for selected groups are provided. Finally, recommendations for developing and implementing hepatitis B immunization protocols are presented.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528297     DOI: 10.1016/0002-9343(89)90530-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  29 in total

1.  Immune response against HBsAg vaccine.

Authors:  Maria Cristina Honorati; Andrea Facchini
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

2.  Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.

Authors:  Thanh Q Tran; Carolyn Z Grimes; Dejian Lai; Catherine L Troisi; Lu-Yu Hwang
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

3.  Immunogenicity of recombinant hepatitis B virus vaccine in patients with and without chronic hepatitis C virus infection: a case-control study.

Authors:  Naser Ebrahimi Daryani; Mohsen Nassiri-Toosi; Armin Rashidi; Iman Khodarahmi
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

4.  Association between microRNA polymorphisms and humoral immunity to hepatitis B vaccine.

Authors:  Yongzhen Xiong; Shengli Chen; Ruhong Chen; Weiyan Lin; Jindong Ni
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

5.  T cell responses to hepatitis B surface antigen are detectable in non-vaccinated individuals.

Authors:  Martin R Weihrauch; Michael von Bergwelt-Baildon; Milos Kandic; Martin Weskott; Winfried Klamp; Joachim Rosler; Joachim L Schultze
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

6.  Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy.

Authors:  Luisa Romanò; Cristina Galli; Catia Tagliacarne; Maria Elena Tosti; Claudio Velati; Laura Fomiatti; Maria Chironna; Rosa Cristina Coppola; Mario Cuccia; Rossana Mangione; Fosca Marrone; Francesco Saverio Negrone; Antonino Parlato; Carla Maria Zotti; Alfonso Mele; Alessandro Remo Zanetti
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

7.  Immune response to an indigenously developed r-hepatitis B vaccine in mixed population: study of an accelerated vaccination schedule.

Authors:  A Chowdhury; A Santra; C-M Habibullah; A-A Khan; J Karunakaramaiah; T-S-A Kishore; A-V-R Raju; S Lahiri
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

8.  Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule.

Authors:  Ke Han; Xiaoping Shao; Huizhen Zheng; Chenggang Wu; Jianqiong Zhu; Xiaoli Zheng; Yonghui Zhang
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

9.  Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China.

Authors:  Li Zhang; Jiaye Liu; Jingjing Lu; Bingyu Yan; Lizhi Song; Li Li; Fuqiang Cui; Guomin Zhang; Fuzhen Wang; Xiaofeng Liang; Aiqiang Xu
Journal:  Hum Vaccin Immunother       Date:  2015-08-07       Impact factor: 3.452

10.  Is a low dose of hepatitis B vaccine enough for a rapid vaccination scheme?

Authors:  Ru-Xiang Wang; Greet Boland; Ying Guo; Shao-Ping Lei; Chang-Hong Yang; Juan Chen; Jie Tian; Jin-Ying Wen; Ke-Hong Du; Jan van Hattum; Gijsbert C de Gast
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.